Cinacalcet, a calcimimetic drug, is now used to treat secondary hyperparathyroidism in dialysis patients. The treatment response is varied and failure is common. This study aimed to evaluate factors affecting unsuccessful responses of cinacalcet in chronic dialysis patients with secondary hyperparathyroidism.
PDF的下载单位、IP信息已删除
(2025-6-4)
Theprisoners
无极微光
DW
null
dde
Nole
云天河
aaaa
DOC_XIONG
学术文献互助
aajhajkahna
cdercder
潇洒的惋清
秋风
朴素乌龟
Kao
v0id
arniu2008
七听
xing_xing
皖公网安备34019202002308
